Boehringer Ingelheim Vaccines

Canine

• 

  Recombitek C4 25x 1 Dosis

  Recombitek® C4 contains a lyophilized suspension of a recombinant canarypox vector expressing the HA and F glycoproteins of canine distemper virus; modified live adenovirus type 2, parainfluenza virus, and parvovirus; plus sterile water diluent. Safety and immunogenicity of this product have been demonstrated by vaccination and challenge tests in susceptible dogs.
• 

  Recombitek C6 25x 1 Dosis

  RECOMBITEK® C6 contains a lyophilized suspension of a recombinant canarypox vector expressing the HA and F glycoproteins of canine distemper virus; modified live adenovirus type 2, parainfluenza virus, and parvovirus; and a liquid suspension of inactivated cultures of L. canicola and L. icterohaemorrhagiae. Safety and immunogenicity of this product have been demonstrated by vaccination and challenge tests in susceptible dogs.
• 

  Imrab 3 50x 1 Dosis

  IMRAB® 3 is recommended for the vaccination of healthy cats, dogs, sheep, cattle, horses, and ferrets 12 weeks of age and older for prevention of disease due to rabies virus. IMRAB® 3 contains the same virus strain that is used in the Pasteur Merieux Connaught human vaccine. The virus is grown in a stable cell line, inactivated, and mixed with a safe and potent adjuvant. Safety and immunogenicity of this product have been demonstrated by vaccination and challenge tests in susceptible animals.